Search clinical trials for: Indoximod base formulation
Total 9613 results
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Korea, Republic of
-
Shanghai Institute Of Biological ProductsShanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruiting
-
Amai Charitable TrustUnknown
-
Cosmetique Active InternationalInnovaderm Research Inc.Terminated
-
LEO PharmaBayerCompleted
-
Merck Sharp & Dohme LLCCompletedCervical Cancer | HPV | Premalignancy Anogenital Warts
-
AllerganCompletedAlopecia | BaldnessUnited States, Germany
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPediatric | Multidrug Resistant TuberculosisPhilippines, South Africa
-
TakedaCompletedHealthy VolunteersUnited States
-
LEO PharmaCompleted
-
Ottawa Heart Institute Research CorporationCompletedCoronary Heart Disease | Valve Disease, HeartCanada
-
AstraZenecaQuotient SciencesCompleted
-
Cerevel Therapeutics, LLCCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedPneumonia | Pneumococcal Infections | Streptococcus Pneumoniae InfectionsBangladesh
-
Supplement Formulators, Inc.CompletedInflammationUnited States
-
Advagene Biopharma Co. Ltd.Taipei Medical University; Clinipace WorldwideCompletedAllergic RhinitisTaiwan
-
Ansun Biopharma, Inc.Completed
-
GlaxoSmithKlineCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedRespiratory Syncytial Virus InfectionHonduras, United States, Chile
-
Boehringer IngelheimActive, not recruiting
-
CytokineticsCompletedChronic Heart Failure | Pharmacokinetics | Left Ventricular Systolic Dysfunction | Left Ventricular Ejection Fraction | Modified Release Oral Formulation | History of Chronic Heart Failure | EchocardiogramUnited States, Canada, Italy, Netherlands, United Kingdom, Belgium, Czechia, Australia, Hungary, Poland, Bulgaria, Lithuania, Germany
-
Chong Kun Dang PharmaceuticalCompletedCardiovascular DiseasesKorea, Republic of
-
McMaster UniversityAjinomoto USA, INC.CompletedPsychological Phenomena: Central FatigueCanada
-
The Hong Kong Polytechnic UniversityRecruitingEducational ProblemsHong Kong
-
AllerganCompletedAlopecia | Alopecia, Androgenetic | BaldnessUnited States, Germany
-
Sanofi Pasteur, a Sanofi CompanyTerminatedCOVID-19United States, Australia, Brazil, Honduras
-
GlaxoSmithKlineCompletedInfections, StreptococcalCzechia
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
MediWound LtdRecruitingNodular Basal Cell Carcinoma | Superficial Basal Cell CarcinomaUnited States
-
Scarless Laboratories, Inc.ethica Clinical Research Inc.Completed
-
TakedaCompletedHypothyroidismBelgium
-
Zuyderland Medisch CentrumNot yet recruitingCervical Intraepithelial Neoplasia-II | High Risk Human Papillomavirus
-
Universiti Sultan Zainal AbidinUniversiti Sains Malaysia; National University of MalaysiaCompletedAt Risk of Type 2 Diabetes MellitusMalaysia
-
GlaxoSmithKlineCompleted
-
Healthy Drink Discoveries, Inc.CompletedHyperlipidemiaUnited States
-
GlaxoSmithKlineCompletedInfections, PapillomavirusUnited States, Spain, Finland, Germany, Taiwan, Belgium, Philippines, Canada, Australia, United Kingdom, Thailand, Brazil, Italy, Mexico
-
Christopher BellCaliper FoodsActive, not recruiting
-
The University of Hong KongCenters for Disease Control and Prevention; Hospital Authority, Hong KongActive, not recruitingInfluenza, HumanChina
-
Chong Kun Dang PharmaceuticalUnknownCardiovascular DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
GlaxoSmithKlineCompleted
-
Medical College of WisconsinCompleted
-
University of FloridaFood and Drug Administration (FDA)Completed
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineLondon School of Hygiene and Tropical Medicine; PATH; Medical Research Council... and other collaboratorsCompletedInfections, StreptococcalGambia
-
GlaxoSmithKlineCompleted
-
Idorsia Pharmaceuticals Ltd.CompletedSafety, Tolerability, Pharmacokinetics and PharmacodynamicsFrance
-
ViiV HealthcareGlaxoSmithKlineCompleted